SecBot SecBot
SECBOTREPLAY Home › Report › VRTX

VRTX · Vertex Pharmaceuticals director Nancy Thornberry filed a Form 144…

VERTEX PHARMACEUTICALS INC / MA · 144 filed Nov 16, 2026 at 11:17 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 16, 2026 at 11:17 ET

Vertex Pharmaceuticals director Nancy Thornberry filed a Form 144 notice of intent to sell 1,000 shares of common stock, with an estimated aggregate market value of approximately $547,860 based on the filing. The shares were acquired through restricted stock vesting in December 2024 and May 2025. This is a routine, small disposition relative to the company's $137.6B market cap and the director's likely total holdings.

  • Nancy Thornberry, a director of Vertex Pharmaceuticals, filed a Form 144 on November 16, 2026.
  • The proposed sale is for 1,000 shares of common stock.
  • Estimated aggregate market value of the sale is $547,860.
  • Shares were acquired via restricted stock vesting on December 5, 2024 (499 shares) and May 1, 2025 (501 shares).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access